Skip to content

Efficacy and Safety Study of rTMS for Upper Extremity Motor Function Recovery in Ischemic Stroke Patients

A Randomized, Double-Blind, Sham-Controlled, Multi-center Clinical Trial to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients With Ischemic Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02082015
Acronym
TAMAS
Enrollment
77
Registered
2014-03-07
Start date
2014-04-30
Completion date
2018-02-28
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Hemiplegia

Keywords

Neuronal plasticity, Transcranial magnetic stimulation, Stroke, Upper extremity, Function, Recovery

Brief summary

The purpose of this study is to Evaluate Efficacy and Safety of rTMS 『TMS』 for Upper Extremity Motor Function Recovery in Patients with Ischemic Stroke

Detailed description

Repetitive transcranial magnetic stimulation (rTMS) can modulate the excitability of cortex but exact efficacy and safety of rTMS is not well established. Eighty four patients will be recruited and will be divided into two groups. Each group will receive the real rTMS or sham rTMS, respectively, over the primary motor cortex of the dominant hand. Individual subject will receive ten sessions of rTMS. Each rTMS session is low frequency (1Hz), total 1800 stimulations. The purpose of this study is to evaluate efficacy and safety of rTMS 『TMS』 for upper extremity motor function recovery in patients with ischemic stroke.

Interventions

Intensity: 100% of resting motor threshold; Location: Motor hotspot in primary motor cortex for the dominant hand; Frequency: 1Hz; Number of total stimuli: 1800; Coil orientation: tangential to scalp

Sponsors

DongGuk University
CollaboratorOTHER
Seoul National University Hospital
CollaboratorOTHER
REMED
CollaboratorUNKNOWN
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 20-80 yrs old * Radiologically confirmed ischemic stroke within 90 days * Brunnström stage 3-5 in the affected hand (ischemic stroke-induced hemiplegic side) * Patients received stroke treatment and on secondary prevention medication * Written informed consent

Exclusion criteria

* Previous medical histories of stroke, cerebral vascular operation, seizure * Pregnancy, Breastfeeding * Patients with hemorrhagic stroke, traumatic brain injury * Skin lesion in the stimulation site of scalp * Metal implants in the body (cardiac pacemaker or aneurysm clip) * Unable to have regular physical and occupational therapies on the affected hand

Design outcomes

Primary

MeasureTime frameDescription
Box and Block Test (affected hand)up to 17 daysBefore rTMS (baseline) and 10 days after the completion of 10 sessions of rTMS

Secondary

MeasureTime frameDescription
Box and Block Test (Affected and unaffected hand)up to 40 daysBefore rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
Barthel Indexup to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
National Institutes of Health Stroke Scaleup to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
Fugl-Meyer Assessment Scaleup to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
Finger tappingup to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
B-stage (hand and arm)up to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
Modified Ashworth scale (wrist flexor and extensor, Elbow flexor and extensor, Long finger flexor spasticity)up to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start
Grip strength (hand grip, pinch grip, lateral prehension, three jaw chuck)up to 40 days10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Other

MeasureTime frameDescription
Vital Signup to 40 daysBefore rTMS (baseline), 10 days after the completion of 10 sessions of rTMS, 40 days after rTMS start

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026